Literature DB >> 11259088

Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus.

N Yamamoto1, K Uzawa, T Yakushiji, T Shibahara, H Noma, H Tanzawa.   

Abstract

Loss of heterozygosity (LOH) on the long arm of chromosome 21 (21q) is observed in several human malignancies. We identified novel tumour suppressor loci on this region in primary oral squamous cell carcinomas (OSCCs). To further determine the role of 21q deletions in oral cavity tumorigenesis, 63 OSCCs were examined for LOH at 21q using 7 microsatellite markers. LOH was observed in 32 of 63 cases (50.8%) that were informative for at least one of the loci analysed. Two distinct deleted regions were identified at chromosomal region 21q11.1. The possible involvement of ANA (abundant in neuroepithelium area), a candidate tumour suppressor gene (TSG) located on 21q11.2--21.1, was also evaluated for 20 OSCCs and 9 OSCC-derived cell lines. 60% of tumours (12/20) and 88.9% (8/9 cell lines) showed absent or reduced mRNA gene expression; only one OSCC case had a nucleotide substitution in the ANA gene. Interestingly, the frequency of the suppressed ANA mRNA expression was greater in stage IV tumours than in earlier stages. In addition, re-expression of the ANA gene mRNA was induced in 4 cell lines after treatment with 5-aza-2'-deoxycytidine, a DNA demethylating agent. These findings demonstrate that there may be at least 2 distinct TSGs on 21q11.1; loss of ANA gene expression could be involved in the progression of human OSCC; and aberrant methylation of the ANA gene promoter may participate in the transcriptional silencing of the gene in oral cancer cells. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259088      PMCID: PMC2363813          DOI: 10.1054/bjoc.2000.1656

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senescence-like state.

Authors:  S Timmermann; P W Hinds; K Münger
Journal:  Oncogene       Date:  1998-12-31       Impact factor: 9.867

2.  Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.

Authors:  R F Schwerdtle; S Störkel; C Neuhaus; H Brauch; E Weidt; W Brenner; R Hohenfellner; C Huber; H J Decker
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

3.  Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: evidence for three discrete tumor suppressor gene loci.

Authors:  N Yamamoto; K Uzawa; T Miya; T Watanabe; H Yokoe; T Shibahara; H Noma; H Tanzawa
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

4.  Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25.

Authors:  X L Wang; K Uzawa; F L Imai; H Tanzawa
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

5.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

6.  Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas.

Authors:  J S Largey; S J Meltzer; J J Sauk; C A Hebert; D W Archibald
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-03

7.  An allelotype of squamous carcinoma of the head and neck using microsatellite markers.

Authors:  K W Ah-See; T G Cooke; I R Pickford; D Soutar; A Balmain
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

8.  Three discrete regions of deletion at 3p in head and neck cancers.

Authors:  R Maestro; D Gasparotto; T Vukosavljevic; L Barzan; S Sulfaro; M Boiocchi
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

9.  Allelotype study of esophageal carcinoma.

Authors:  T Aoki; T Mori; X Du; T Nisihira; T Matsubara; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1994-07       Impact factor: 5.006

10.  High prevalence of p16 genetic alterations in head and neck tumours.

Authors:  E C Miracca; L P Kowalski; M A Nagai
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  13 in total

1.  Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.

Authors:  Shahana Majid; Altaf A Dar; Varahram Shahryari; Hiroshi Hirata; Ardalan Ahmad; Sharanjot Saini; Yuichiro Tanaka; Angela V Dahiya; Rajvir Dahiya
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

2.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

3.  Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer.

Authors:  X L Ren; X H Zhu; X M Li; Y L Li; J M Wang; P X Wu; Z B Lv; W H Ma; W T Liao; W Wang; Y Q Ding; L Liang
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-20       Impact factor: 4.553

4.  Direct Downregulation of B-Cell Translocation Gene 3 by microRNA-93 Is Required for Desensitizing Esophageal Cancer to Radiotherapy.

Authors:  Hujun Cui; Shengqiang Zhang; Hongbo Zhou; Ling Guo
Journal:  Dig Dis Sci       Date:  2017-04-22       Impact factor: 3.199

5.  BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Authors:  Shahana Majid; Altaf A Dar; Ardalan E Ahmad; Hiroshi Hirata; Kazumori Kawakami; Varahram Shahryari; Sharanjot Saini; Yuichiro Tanaka; Angela V Dahiya; Gaurav Khatri; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2009-02-12       Impact factor: 4.944

6.  The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.

Authors:  Yi-Hung Ou; Pei-Han Chung; Fu-Fei Hsu; Te-Ping Sun; Wen-Ying Chang; Sheau-Yann Shieh
Journal:  EMBO J       Date:  2007-08-09       Impact factor: 11.598

7.  Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes.

Authors:  Pawadee Lohavanichbutr; John Houck; David R Doody; Pei Wang; Eduardo Mendez; Neal Futran; Melissa P Upton; F Christopher Holsinger; Stephen M Schwartz; Chu Chen
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.

Authors:  Boya Deng; Yang Zhao; Wenfeng Gou; Shuo Chen; Xiaoyun Mao; Yasuo Takano; Huachuan Zheng
Journal:  Tumour Biol       Date:  2013-05-09

9.  Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma.

Authors:  T Onda; K Uzawa; Y Endo; H Bukawa; H Yokoe; T Shibahara; H Tanzawa
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

10.  The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.

Authors:  Zhenbing Lv; Huichun Zou; Kaiwen Peng; Jianmei Wang; Yi Ding; Yuling Li; Xiaoli Ren; Feifei Wang; Rui Chang; Li Liang; Yanqing Ding
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.